Pankaj Makkar, managing director, Bertelsmann India Investments (BII), spoke to S Shanthi how the firm is going about ...

The annual JPM Healthcare Conference held in early January sets the stage for the year of life science deals. Unlike the pre-COVID days when ...

As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: ...

Arne Alsin of Nightview Capital discusses the 2025 outperformance of the NITE ETF and his bullish outlook on physical AI.

AI is forcing private equity and venture capital firms to rethink traditional investment metrics. How investors are adapting ...

For decades, “private credit” was synonymous with rigid structures and standardized term loans with fixed covenants that resembled off-the-shelf products. That’s changing. Today, wha ...

Bengaluru, India-based Ethereal Exploration Guild is developing the world’s first fully (booster and upper stage) reusable medium-lift launch vehic ...

TradeWinds depends on being able to display ads on our services in order to finance our journalism.

How HTGF combines government backing and industrial partnerships with a VC mindset to crowd in private capital and support ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

China's electronics sector became the largest industry by total market capitalization in the A-share market last year, ...

After years of enthusiasm around alternative proteins, cellular agriculture startups are facing a far more sobering capital ...